These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Involvement of thiol groups in the impairment of cardiac sarcoplasmic reticular phospholipase D activity by oxidants. Dai J; Meij JT; Dhalla V; Panagia V J Lipid Mediat Cell Signal; 1995 Mar; 11(2):107-18. PubMed ID: 7780680 [TBL] [Abstract][Full Text] [Related]
4. Oxidants depress the synthesis of phosphatidylinositol 4,5-bisphosphate in heart sarcolemma. Mesaeli N; Tappia PS; Suzuki S; Dhalla NS; Panagia V Arch Biochem Biophys; 2000 Oct; 382(1):48-56. PubMed ID: 11051096 [TBL] [Abstract][Full Text] [Related]
8. Depression of heart sarcolemmal Ca2+-pump activity by oxygen free radicals. Kaneko M; Beamish RE; Dhalla NS Am J Physiol; 1989 Feb; 256(2 Pt 2):H368-74. PubMed ID: 2537032 [TBL] [Abstract][Full Text] [Related]
9. Alterations in heart sarcolemmal Ca2(+)-ATPase and Ca2(+)-binding activities due to oxygen free radicals. Kaneko M; Singal PK; Dhalla NS Basic Res Cardiol; 1990; 85(1):45-54. PubMed ID: 2158297 [TBL] [Abstract][Full Text] [Related]
10. Impairment of the sarcolemmal phospholipase D-phosphatidate phosphohydrolase pathway in diabetic cardiomyopathy. Williams SA; Tappia PS; Yu CH; Bibeau M; Panagia V J Mol Cell Cardiol; 1998 Jan; 30(1):109-18. PubMed ID: 9500869 [TBL] [Abstract][Full Text] [Related]
11. Subcellular alterations in cardiac phospholipase D activity in chronic diabetes. Williams SA; Tappia PS; Yu CH; Binaglia L; Panagia V; Dhalla NS Prostaglandins Leukot Essent Fatty Acids; 1997 Jul; 57(1):95-9. PubMed ID: 9250614 [TBL] [Abstract][Full Text] [Related]
12. Phospholipase A2-mediated activation of phospholipase D in rat heart sarcolemma. Liu SY; Tappia PS; Dai J; Williams SA; Panagia V J Mol Cell Cardiol; 1998 Jun; 30(6):1203-14. PubMed ID: 9689594 [TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of the effect of cis-unsaturated fatty acids on heart sarcolemmal phospholipase D activity. Dai J; Williams SA; Ziegelhöffer A; Panagia V Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):167-71. PubMed ID: 7784454 [TBL] [Abstract][Full Text] [Related]
15. Alterations of sarcolemmal phospholipase D and phosphatidate phosphohydrolase in congestive heart failure. Yu CH; Panagia V; Tappia PS; Liu SY; Takeda N; Dhalla NS Biochim Biophys Acta; 2002 Sep; 1584(1):65-72. PubMed ID: 12213494 [TBL] [Abstract][Full Text] [Related]
16. Role of sulfhydryl groups in phospholipid methylation reactions of cardiac sarcolemma. Vetter R; Dai J; Mesaeli N; Panagia V; Dhalla NS Mol Cell Biochem; 1991 Apr; 103(1):85-96. PubMed ID: 1857347 [TBL] [Abstract][Full Text] [Related]
17. Involvement of tyrosine phosphorylation in inhibition of fMLP-induced PLD activation by N-acetyl-L-cysteine in differentiated HL60 cells. Nakamura M; Nakashima S; Katagiri Y; Nozawa Y J Leukoc Biol; 1998 Jun; 63(6):781-9. PubMed ID: 9620673 [TBL] [Abstract][Full Text] [Related]
18. Modification of contractile proteins by oxygen free radicals in rat heart. Kaneko M; Masuda H; Suzuki H; Matsumoto Y; Kobayashi A; Yamazaki N Mol Cell Biochem; 1993 Aug; 125(2):163-9. PubMed ID: 8283971 [TBL] [Abstract][Full Text] [Related]
19. Selective and reversible inhibition of heart sarcolemmal (Na+ + K+)-ATPase by p-bromophenyl isothiocyanate. Evidence for a sulfhydryl group in the ATP-binding site of the enzyme. Ziegelhöffer A; Breier A; Dzurba A; Vrbjar N Gen Physiol Biophys; 1983 Dec; 2(6):447-56. PubMed ID: 6088362 [TBL] [Abstract][Full Text] [Related]
20. Cardiac phospholipase D2 localizes to sarcolemmal membranes and is inhibited by alpha-actinin in an ADP-ribosylation factor-reversible manner. Park JB; Kim JH; Kim Y; Ha SH; Yoo JS; Du G; Frohman MA; Suh PG; Ryu SH J Biol Chem; 2000 Jul; 275(28):21295-301. PubMed ID: 10801846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]